Other
Neoplasm by Cause
CI-CAN-00000032Explore in graph →
Non-malignant195 active trials4 approved drugs1 evidence items
- NCIt
- C27933
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000032Explore in graph →
Clinical trials
708 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00000763 | A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 | 42 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 3, 2021 | clinicaltrials |
| NCT00000694 | A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma | completed | Phase 1 | 18 | National Institute of Allergy and Infectious Diseases (NIAID)NIH |
| 1 |
| Nov 2, 2021 |
| clinicaltrials |
| NCT00000695 | Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma | completed | Phase 1 | 36 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Nov 2, 2021 | clinicaltrials |
| NCT00001114 | The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma | completed | Phase 2 | 90 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 2 | Nov 1, 2021 | clinicaltrials |
| NCT00000954 | A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma | completed | Phase 1 | 72 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 29, 2021 | clinicaltrials |
| NCT00000769 | A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma | completed | Phase 1 | 48 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 28, 2021 | clinicaltrials |
| NCT00000807 | Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy | completed | Phase 2 | 41 | National Institute of Allergy and Infectious Diseases (NIAID)NIH | 1 | Oct 28, 2021 | clinicaltrials |
| NCT03451071 | Postpartum HPV Vaccination | completed | Phase 4 | 195 | University of Alabama at BirminghamOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT04189003 | Molecular Signatures of HPV+ ORL Cancers (OROPAP)(OROPAP) | completed | — | 66 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT04380623 | A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families | unknown | N/A | 244 | Meharry Medical CollegeOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT01805037 | Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas | terminated | Phase 1 / Phase 2 | 20 | Northwestern UniversityOTHER | 1 | Sep 1, 2021 | clinicaltrials |
| NCT04970394 | An Observational Study of GP Verbal Reminders Upon Cervical Screening(VRCS) | completed | — | 724 | Dr. Faizan AwanOTHER | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02973113 | Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)(PREVALE) | completed | Phase 1 | 8 | Baylor College of MedicineOTHER | 1 | Jul 21, 2021 | clinicaltrials |
| NCT04420039 | Plastic Stent Within a Lumen-Apposing Stent for Malignant Biliary Obstruction(LAMSpigBil) | completed | — | 39 | Hospital Universitari de BellvitgeOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT03602898 | Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation | withdrawn | Phase 2 | 0 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT03182959 | Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer | completed | Early Phase 1 | 6 | University of ArizonaOTHER | 1 | Jun 21, 2021 | clinicaltrials |
| NCT04920526 | Effectiveness and B-memory Cell Response to QHPV Vaccine 9-years Post-vaccination Among HIV-infected Boys and Girls | unknown | — | 135 | Kenya Medical Research InstituteOTHER | 0 | Jun 10, 2021 | clinicaltrials |
| NCT02037256 | Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma | completed | N/A | 23 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | May 10, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT03771183 | Loreline Study: Characterization of Long Responders Under Eribuline(Loreline) | completed | — | 97 | Centre Jean PerrinOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT01678443 | Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies | terminated | Phase 1 | 2 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2021 | clinicaltrials |
| NCT01307579 | Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia | completed | Phase 3 | 517 | Children's Oncology GroupNETWORK | 3 | Mar 30, 2021 | clinicaltrials |
| NCT04705129 | Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL | unknown | Phase 2 | 40 | Ruijin HospitalOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT04476459 | Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL | unknown | Phase 1 / Phase 2 | 33 | Huiqiang HuangOTHER | 1 | Mar 15, 2021 | clinicaltrials |
| NCT04796857 | Tislelizumab in Combination With Lenalidomide in Refractory and Relapsed Elderly Patients With Non-GCB DLBCL | unknown | Phase 1 / Phase 2 | 30 | Huiqiang HuangOTHER | 1 | Mar 15, 2021 | clinicaltrials |
| NCT00339326 | Risk Factors for Non-HIV-Related Kaposi s Sarcoma | completed | — | 1,383 | National Cancer Institute (NCI)NIH | 1 | Mar 12, 2021 | clinicaltrials |
| NCT01276236 | Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) | completed | Phase 2 | 13 | University of California, San FranciscoOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT02624349 | Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients | completed | Phase 4 | 37 | The Hospital for Sick ChildrenOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT00489203 | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer | completed | Phase 2 | 140 | Fred Hutchinson Cancer CenterOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT03160183 | Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi | completed | — | 157 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT00395278 | Development of Serologic Assays for Human Herpes Virus-8 | completed | — | 394 | National Institutes of Health Clinical Center (CC)NIH | 1 | Dec 11, 2020 | clinicaltrials |
| NCT02580552 | Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL | completed | Phase 1 | 66 | miRagen Therapeutics, Inc.INDUSTRY | 1 | Nov 23, 2020 | clinicaltrials |
| NCT01258998 | Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Nov 4, 2020 | clinicaltrials |
| NCT03050788 | Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma | completed | N/A | 363 | Massachusetts General HospitalOTHER | 1 | Oct 26, 2020 | clinicaltrials |
| NCT01075321 | Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 58 | Mayo ClinicOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT02670616 | Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma | completed | Phase 2 | 24 | Samsung Medical CenterOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT03963024 | Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT(TrRaMM-TMI) | terminated | Phase 1 | 9 | IRCCS San RaffaeleOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT04520464 | Clinical Trial Comparing the Self-test for Cervicovaginal Sample Versus Samples From Service Provider (Xyto-Ro)(Xyto-Ro) | unknown | N/A | 444 | Hospital General de México Dr. Eduardo LiceagaOTHER_GOV | 1 | Aug 20, 2020 | clinicaltrials |
| NCT04510077 | SmartQuit Program for Smoking Cessation | completed | N/A | 99 | Fred Hutchinson Cancer CenterOTHER | 1 | Aug 12, 2020 | clinicaltrials |
| NCT00695422 | Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials | completed | — | 47 | AIDS Malignancy ConsortiumNETWORK | 1 | Aug 10, 2020 | clinicaltrials |
| NCT03105856 | FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program(FASTER) | completed | Phase 4 | 3,000 | Instituto Nacional de Salud Publica, MexicoOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT03526926 | A Post-Marketing Observational Study of VYXEOS™ | completed | — | 52 | Jazz PharmaceuticalsINDUSTRY | 1 | Aug 5, 2020 | clinicaltrials |
| NCT04480866 | CASUS: Improved and Quality Assured Collection of First-void Urine(CASUS-WP1) | completed | N/A | 25 | Universiteit AntwerpenOTHER | 1 | Jul 21, 2020 | clinicaltrials |
| NCT00026793 | Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions | completed | — | 29 | National Cancer Institute (NCI)NIH | 1 | Jul 8, 2020 | clinicaltrials |
| NCT00267865 | Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma | completed | Phase 2 | 12 | National Cancer Institute (NCI)NIH | 1 | Jun 1, 2020 | clinicaltrials |
| NCT03075553 | Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma | terminated | Phase 2 | 12 | Mayo ClinicOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT00082888 | Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 1 | Apr 13, 2020 | clinicaltrials |
| NCT00410475 | Cancer Risk in X-Ray Technologists: Second Survey | completed | — | 146,022 | National Cancer Institute (NCI)NIH | 1 | Apr 7, 2020 | clinicaltrials |
| NCT01729429 | An Intervention Promoting HPV Vaccination in Safety-net Clinics | completed | N/A | 831 | University of Texas Southwestern Medical CenterOTHER | 1 | Mar 18, 2020 | clinicaltrials |
| NCT00918333 | Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 124 | Mayo ClinicOTHER | 1 | Mar 10, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Nov 3, 2021source: clinicaltrials